Items | Intervention period (weeks) | End of the exercise (weeks) | Follow-up (weeks) | Outcome assessment (weeks) | Follow-up (weeks) | End of the follow-up(weeks) | |
---|---|---|---|---|---|---|---|
9-12 | 12 | 13-18 | 18 | 19-24 | 24 | ||
Recruitment | Â | Â | Â | Â | Â | Â | |
Inclusion criteria | Â | Â | Â | Â | Â | Â | |
Exclusion criteria | Â | Â | Â | Â | Â | Â | |
Informed consent | Â | Â | Â | Â | Â | Â | |
Basic characteristic variables | Â | Â | Â | Â | Â | Â | |
Randomization and allocation concealment | Â | Â | Â | Â | Â | Â | |
Primary outcomes | Berg balance scale |  | × |  | × |  | × |
Secondary outcomes | Simplified Fugl - Meyer motor function assessment |  | × |  | × |  | × |
 | Modified barthel index |  | × |  | × |  | × |
The Medical outcomes study 36-Item Short-Form health survey |  | × |  | × |  | × | |
Beck depression inventory |  | × |  | × |  | × | |
Modified falls efficacy scale |  | × |  | × |  | × | |
Single leg stance test |  | × |  | × |  | × | |
Timed-Up-and-Go test |  | × |  | × |  | × | |
Blood glucose and blood lipid |  | × |  |  |  |  | |
Proprioception function |  | × |  |  |  |  | |
Cardiopulmonary function |  | × |  |  |  |  | |
Gait analysis |  | × |  |  |  |  | |
Adverse events recorded | × |  | × |  | × |  | |
Medication and fall self-report | × |  | × |  | × |  | |
Rehabilitation costs questionnaire | × |  | × |  | × |  |